Ergoline amine derivatives with blood pressure lowering effect
    3.
    发明授权
    Ergoline amine derivatives with blood pressure lowering effect 失效
    艾曲林胺衍生物具有降血压作用

    公开(公告)号:US06358967B1

    公开(公告)日:2002-03-19

    申请号:US09743869

    申请日:2001-04-19

    IPC分类号: A61K3148

    摘要: The invention relates to novel derivatives of ergoline of the general formula 1 in which R1 together with the two adjacent N atoms is the residue of a diamine and R4 together with the two adjacent carbonyl groups is the residue of a dicarboxylic acid. R2, R3, R6, R7, R8 can be H or an organic radical. R7 and R8 are H or together are a bond. The compounds show a strong antihypertensive effect. These effects moreover occur after intravenous and enteral administration even at dosages in the region of a few &mgr;g/kg (body weight). The compounds can accordingly be used as pharmaceuticals for hypertensive diseases in human medicine.

    摘要翻译: 本发明涉及通用1的麦角灵素的新衍生物,其中R1与两个相邻的N原子一起是二胺的残基,R4与两个相邻的羰基一起是二羧酸的残基。 R2,R3,R6,R7,R8可以是H或有机基团。 R7和R8是H或一起是一个键。化合物显示出强烈的抗高血压作用。 即使在几公斤/公斤(体重)的剂量下,静脉内和肠内给药也会发生这些影响。 因此,这些化合物可以用作人类医学中的高血压疾病的药物。